Skip to main content
OpenTrials
Completed

NCT Number: NCT00241566

Economic Medical Evaluation of Treatment of the Neuropathic Pain Rebel by Cortical Stimulation

All neuropathic chronicle pains are difficult to treat. Currently many patients are not relieved by electric stimulations of central nervous system, existing. Recently cortical stimulation had a development important and benefit effects are proven. In this study we evaluate medico-economic impact of this treatment.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Clermont-Ferrand UH, Clermont-Ferrand, Auvergne, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Presence of pain caused by lesion of central or peripheral nervous system
  • Pain persistent since one year at least
  • Pain untreated with 3 different antalgic treatments

Exclusion criteria

  • Pain linked t a malignant affection
  • patient < 18 years-old

Treatment and study plan

implantation of stimulator

Device

Primary outcomes

  1. Cost of treatment of this pathology

Secondary outcomes

  1. Evaluation of the pain when the electric stimulation is off or on (during one month for each one). Using Visual Analogic Scale.

Sponsors and collaborators

Lead sponsor

University Hospital, Clermont-Ferrand

Other

Registry information

Important dates

Study start
2003
Primary completion
2007
Study completion
2007
First posted
Oct 19, 2005
Registry last updated
Jan 20, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.